JJ
Johnson & Johnson Portfolio holdings
AUM
$334M
This Quarter Return
-19.75%
1 Year Return
+16.18%
3 Year Return
+88.55%
5 Year Return
–
10 Year Return
–
AUM
$1.14B
AUM Growth
–
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
95.42%
Holding
25
New
25
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Illumina
ILMN
|
$329M |
| 2 |
Arrowhead Research
ARWR
|
$204M |
| 3 |
Fate Therapeutics
FATE
|
$200M |
| 4 |
Legend Biotech
LEGN
|
$82.4M |
| 5 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
$65.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.87% |
| 2 | Technology | 0.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Illumina
ILMN
$15.8B
| $329M | 28.83% | +810,170 | New | +$329M |
|
|
2
Arrowhead Research
ARWR
$3.05B
| $204M | 17.86% | +3,260,869 | New | +$204M |
|
|
3
Fate Therapeutics
FATE
$120M
| $200M | 17.57% | +3,379,064 | New | +$200M |
|
|
4
Legend Biotech
LEGN
$6.41B
| $82.4M | 7.23% | +1,629,173 | New | +$82.4M |
|
|
HLTH
5
DELISTED
Cue Health Inc. Common Stock
HLTH
| $65.5M | 5.75% | +5,548,864 | New | +$65.5M |
|
6
CVRx
CVRX
$205M
| $57.8M | 5.07% | +3,495,575 | New | +$57.8M |
|
7
Protagonist Therapeutics
PTGX
$3.67B
| $43.4M | 3.81% | +2,449,183 | New | +$43.4M |
|
8
Procept Biorobotics
PRCT
$2.23B
| $38.9M | 3.41% | +1,018,478 | New | +$38.9M |
|
9
MeiraGTx Holdings
MGTX
$587M
| $38.2M | 3.35% | +2,898,550 | New | +$38.2M |
|
|
FUSN
10
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $29.1M | 2.55% | +3,670,516 | New | +$29.1M |
|
11
Vor Biopharma
VOR
$250M
| $16.9M | 1.48% | +1,074,658 | New | +$16.9M |
|
|
PNT
12
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $7.69M | 0.67% | +1,000,000 | New | +$7.69M |
|
13
BiomX
PHGE
$14.3M
| $6.53M | 0.57% | +2,133,402 | New | +$6.53M |
|
14
Adicet Bio
ACET
$59.9M
| $5.72M | 0.5% | +728,944 | New | +$5.72M |
|
|
PHAS
15
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $5M | 0.44% | +1,607,044 | New | +$5M |
|
|
SLGC
16
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $3.48M | 0.31% | +281,052 | New | +$3.48M |
|
17
Aldeyra Therapeutics
ALDX
$351M
| $3.47M | 0.3% | +394,834 | New | +$3.47M |
|
|
CSLT
18
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.27M | 0.11% | +811,295 | New | +$1.27M |
|
19
Neuropace
NPCE
$303M
| $879K | 0.08% | +55,435 | New | +$879K |
|
|
TCON
20
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $325K | 0.03% | +84,003 | New | +$325K |
|
21
Gyre Therapeutics
GYRE
$703M
| $275K | 0.02% | +66,951 | New | +$275K |
|
|
ZY
22
DELISTED
Zymergen Inc. Common Stock
ZY
| $218K | 0.02% | +16,553 | New | +$218K |
|
23
Pulmonx
LUNG
$69.7M
| $203K | 0.02% | +5,639 | New | +$203K |
|
24
Senseonics Holdings
SENS
$374M
| $185K | 0.02% | +54,621 | New | +$185K |
|
25
CalciMedica
CALC
$37.7M
| $164K | 0.01% | +49,547 | New | +$164K |
|